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Summary: The complete sequencing of genomes and the development of in 
silico methods for identification of genes encoding selenocysteine (Sec)- 
containing proteins have greatly contributed to shape our view on the 
evolution of selenium utilization in nature. Current evidence is consistent 
with the idea that Sec decoding is a late addition to the genetic code and it 
evolved once, before the separation of archaeal, bacterial and eukaryal 
domains. Many organisms have lost the Sec decoding trait, but recent 
evidence has shown that the loss is not irreversible. The distribution of 
organisms that use UGA as a Sec codon suggests that Sec decoding evolved 
as a result of speciation, differential gene loss and horizontal gene transfer. 
Selenium is also used in the synthesis 2-selenouridine, a modified base of 
unknown function located in the wobble position of certain tRNAs. It has 
been recently demonstrated that selenouridine and Sec-decoding traits can 
evolve independently of each other, but both require selenophosphate 
synthetase. This ATP-dependent enzyme emerged as a key feature of 
selenium utilization that allows separation of selenium from the pathways of 
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sulfur utilization and non-specific use of selenium. Some animals, including 
mammals, evolved two selenophosphate synthetases, highlighting an 
unknown complexity of selenium utilization in nature. 
Introduction 
Co-translational incorporation of selenocysteine (Sec) into nascent 
polypeptides is neither canonical nor universal. A Sec-decoding apparatus is 
needed to reprogram specific UGA codons [I-31. The Sec-decoding 
apparatus and selenoprotein genes are present in the three domains of life; 
yet, many taxa lack them. In Sec decoding species, the selenoproteome 
consists of a restricted number of proteins [4,5]. All these observations have 
raised important questions regarding the evolution of Sec utilization in 
nature. For example, how and when did the translation machinery to decode 
Sec evolve? If it evolved once, has it been perpetuated solely by vertical 
descent? Has the UGA codon evolved from nonsense to sense or vice versa? 
Have extant selenoproteins evolved from Cys-containing proteins or vice 
versa? What are the selective forces that result in maintenance, loss and 
acquisition of the Sec-decoding trait and selenoproteins? In a broader 
scenario, studies on the evolution of Sec invite more in-depth questions 
regarding the evolution of the genetic code and the translation machinery. 
Recent work allowed some of these questions to be answered providing a 
provisional evolutionary scenario [S-71. At the same time, some unknowns 
remain. In this chapter we review the current knowledge regarding Sec and 
selenium utilization in nature, their evolution, and highlight a key role of 
selenophosphate synthetase in these processes. 
Sec decoding: common origin before the division of the three domains? 
Current evidence strongly suggests that the Sec decoding trait evolved once, 
before the division of bacterial, archaeal and eukaryal domains. For example, 
there are fundamental similarities in the three domains: i) Sec is decoded by 
UGA-matching ~ R N A ~ ~  (also known as selC) and a dedicated elongation 
factor (EFsec, also known as selB); ii) the translational reprogramming is 
fulfilled by the SECIS element present in selenoprotein rnRNAs; and iii) Sec 
synthesis occurs on a tRNA scaffold as reviewed in [2,3,8,9]. A common 
origin is further supported by the recent phylogenetic analysis of the genes 
involved in Sec decoding [7], which indicates that the trait is monophyletic 
in the bacterial domain and that eukaryal and archaeal Sec-decoding genes 
have a common ancestor. These observations suggest that the most 
parsimonious and likely evolutionary scenario for the trait is a common 
origin between the three domains, and not independent origins. The greater 
similarity between archaeal and eukaryal domains may reflect the fact that 
the transcription and translation machinery in archaea and eukarya is thought 
to be of common origin. Further studies should be carried out to identifl and 
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date the time of divergence of the different genes involved in Sec decoding 
and compare these patterns with divergence of the three domains. Syvanen 
[lo] has proposed that the unity of the genetic code is the product of an 
evolutionary process that has continued since the diversification of the major 
domains and specifically suggested that the last common ancestor (which 
defines the origin of the three domains) did not use arginine and tryptophan. 
In this alternative scenario, horizontal gene transfer (HGT) would have 
played a critical role in homogenization of the code. If this proposition is 
correct, it is then possible that Sec might not have been the 2lSt amino acid 
added to the genetic code. 
Despite the remarkable similarities, differences do exist in the Sec- 
decoding traits in the three domains of life, including an increased 
complexity of the pathway in eukaryotes 111-141. It has been argued that the 
differences between bacterial and eukaryal Sec incorporation are due to a 
refinement of the mechanism to provide an increased efficiency in Sec 
incorporation [15]. It is also likely that some changes favored a greater 
flexibility in reprogramming. Indeed, the location of the SECIS element 
within the untranslated region in archaea and eukarya released the 
constraints imposed by the location of SECIS immediately downstream of 
U G A ~ '  within the coding region of bacterial messages. 
The Sec decoding trait can be lost, but not irreversibly 
Recently, the distribution of the Sec-decoding trait was analyzed 
systematically by searching complete genomes for the presence of genes 
involved in Sec decoding and selenoprotein(s) and using this information to 
construct a provisional "Sec decoding map" within the "tree of life" 171. This 
study revealed that the trait is present in most phyla, but absent in many 
species, and provided clues regarding the evolution of Sec. Then, the 
phylogenies of the Sec-decoding genes were inferred and compared to 
organisrnal phylogenies. This approach explained the spread and "holed" 
pattern of Sec-decoding species within the tree of life as the result of 
speciation, differential gene loss and horizontal gene transfer (HGT). It also 
revealed that the loss of the trait is a phenomenon that takes place within 
clades at different evolutionary levels, implying that the loss occurred not 
only at rather basal evolutionary levels (e.g., phylum and class), but also in 
recent lineages (e.g., genus and species). A  stunning example of the latter is 
the case of the C092 and mediaevalis strains of Yersinia pestis that have lost 
the ability to decode Sec (possess functional ~RNA- and Sec synthase but 
an EFsec pseudogene) while the KIM strain retains this ability 
(unpublished). Yet, the main disclosure of the study was that it clearly 
demonstrated that the loss of the trait was not irreversible, indicating that the 
genetic code can be "rewired" by HGT, a possibility previously thought as 
highly unlikely [16]. This phenomenon was patently observed in the case of 
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Photobacterium profundum, which did not acquire its extant trait and the 
selenoproteins involved in the glycine reductase complex by vertical descent 
from a proteobacterial ancestor, but rather from a different lineage. 
Incongruences possibly attributable to HGT, between gene and species trees 
were also observed in the case of Pseudomomas spp. (y-proteobacteria), 
Sinorhizobium meliloti (a-proteobacterium) and Burkholderia spp (P- 
proteobacteria). In these species, the only selenoprotein is the a-subunit of 
formate dehydrogenase. In this regard, it should be noted that Pseudomonas 
spp, S. meliloti and Burkholderia pseudomallei are soil colonizing bacteria 
[17,18]; whereas S. meliloti and Pseudomonas spp. even compete for 
nodulation on some plants. It was speculated that a putative vector for 
acquisition of the trait may exist, on the basis of the observation that S. 
meliloti contains the genetic information for selenoproteins and the Sec- 
decoding trait within a megaplasmid (pSymA) with a high number of 
transposons [I 51. 
Selenophosphate synthetase: an essential enzyme for selenium 
utilization 
Selenophosphate synthetase (SPS) is an essential enzyme for selenium 
utilization: it catalyzes the synthesis of monoselenophosphate [19], a 
reduced and reactive form of selenium, which provides the selenium atom 
for synthesis of Sec and 2-selenouridine, another biologically relevant form 
of selenium in nature (see below and [20]). There appears to be two groups 
of SPS enzymes. One group contains Sec or Cys at the active site and the 
corresponding E. coli enzyme can catalyze, in vitro, the synthesis of 
selenophosphate from selenide and ATP [21] as follows: ATP + HSe' + H20 
H2SePOi + AMP + Pi . It should be emphasized that the Km value for 
selenide is 20 pM, a concentration that would be noxious for the cell in vivo, 
suggesting that selenide would not be the physiological selenium donor for 
SPS2/SelD. The other group (designated SPSl) is present exclusively in 
some eukaryotic organisms that also possess SPS2 (e.g., mammals); SPSl 
neither contains Sec or Cys at the predicted active site position nor appears 
to catalyze the in vitro reaction depicted above [22]. In vivo, human SPS2 
complemented an E. coli selD mutant strain when the medium was 
supplemented with selenite or Sec, restoring the activity of the selenoprotein 
formate dehydrogenase to E. coli wild type levels. In contrast, 
complementation with SPSl was ineffective when selenite was used as a 
selenium supply, although it improved when Sec was used in the medium 
[22]. These results led Tamura et a1 [22] to propose that human SPS2 
functions in the pathway of de novo synthesis of selenophosphate from 
selenite, after reduction of the latter, presumably, by intracellular thiols; the 
Sec residue of SPS2 active site would bind this reduced selenium to form an 
enzyme substrate complex. Alternatively, for SPSl catalysis, mammalian 
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cells would supply an atom of Se derived fiom a Sec salvage pathway that 
may recycle Sec derived from selenoproteins or from the promiscuous 
incorporation of selenium instead of sulfur in the Cys metabolic pathway. 
Sec P-lyases, enzymes that catalyze the conversion of Sec to Ala and a 
selenium transfer form (Se*, since the redox state of Se has not been 
determined), and NifS and NifS-like proteins (enzymes that provide a sulfur 
atom to iron-sulfur clusters by catalyzing Cys desulfuration, and also convert 
Sec to Ala and Se*) are candidate enzymes to participate in selenium 
mobilization fiom Sec [23,24], and have been proposed as key players for 
the Sec-salvage pathway. 
It is relevant to emphasize that the bacterial NifS-like proteins CsdB, CSD, 
and IscS also have an important role in selenium mobilization from Sec and 
selenophosphate synthesis. Indeed, Sec and bacterial NifS-like proteins can 
effectively replace the high level of free selenide in the in vitro SPS assay 
[25,26]. Furthermore, the E. coli SPS (C17S) mutant, which is inactive in the 
standard in vitro assay with selenide as substrate, was found to be active in 
the presence of Sec and NifS proteins, suggesting a selenium delivery 
function for these proteins [26]. Evidence that selenium is mobilized in vivo 
from free Sec has also been obtained by Lacourciere [27]: growth of E. coli 
in the presence 0.1 pM 7 5 ~ e  ~ 0:- and increasing amounts of Sec resulted in 
a concomitant decrease in 7%e incorporation in formate dehydrogenase and 
bulk tRNA. This led Lacourciere to propose that NifS-like proteins are 
components of a selenium delivery system for the biosynthesis of 
selenophosphate. 
Recently, other potential selenium-binding and delivery proteins for SPS 
have been characterized. Human 3 -mercaptopyruvate sulfur transferase 
(MST) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), bound 
selenium supplied as selenodiglutathione formed from s~o:- and 
glutathione; the bound selenium was readily released from MST and 
GAPDH and available as a substrate for bacterial SPS [28]. Thus, in vitro, 
these selenium-binding proteins and a low level of selenodigultathione 
(formed from selenite and glutathione) could effectively replace the high 
concentrations of selenide used in SPS assays. 
Despite this considerable progress, the metabolic pathway(s) of selenium 
assimilation and the physiological system that donates selenium to SPS 
remain to be completely characterized and represents one of the challenges 
ahead in the selenium field. 
Selenophosphate synthetase: one enzyme, two selenium utilization traits 
2-Selenouridine is the second major biological form of Se in nature [29]. It is 
a modified base so far identified exclusively in the wobble position of the 
anticodon of tRNALys, ~ R N A ~ ' "  and ~ R N A ~ "  in some bacteria [30]. 2- 
Selenouridine is synthesized by the protein designated YbbB from 
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thiouridine tRNA and selenophosphate (the latter as the selenium donor). 
Although it was originally thought that organisms able to synthesize 2- 
selenouridine were the same as those able to decode Sec, it has recently been 
shown that the set of organisms that synthesize 2-selenouridine overlaps 
with, yet is distinct from, the set of organisms able to decode Sec (Figure 1). 
only Sec -\ 
incorporatio-  \ 
L SPS n = l  
Figure 1. Sec-decoding and selenouridine (SeU) synthesis traits both require selenophosphate 
synthetase (SPS). However, the set of species that decode Sec overlaps with, but is different 
from, the set of species that synthesize SeU. The representation excludes species of the 
eukaryal domain. Note that there is one species possessing SPS, but neither trait (see text). n= 
numbers of completed prokaryotic genomes. (Total number of complete genomes analyzed 
was 153.) 
Indeed, SPS is required for both Sec and selenouridine synthesis. This study 
allowed us to define SPS as the gene signature of selenium utilization, YbbB 
as the gene signature for 2-selenouridine synthesis and EFsec and ~RNA"' as 
the gene signature of the Sec-decoding trait. Thus, the likely evolutionary 
scenario is that SPS is required for both traits, but Sec-decoding and 2- 
selenouridine synthesis traits can evolve independently of each other. 
Analyses of genomic organization of Se utilization genes in the bacterial 
domain revealed that SPS is more often arranged in an operon with ybbB 
than with EFsec (selB) and Sec synthase (selA). HGT events were also 
identified for the selenouridine synthesis trait; thus, the pattern of species 
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distribution for both Se traits is the result of speciation, differential gene loss 
and HGT. 
An interesting parallel that might be sketched for both traits is the 
restricted use of selenium: it is certainly peculiar that the Sec decoding 
apparatus has been maintained in some species for insertion of a single 
amino acid into a 
single protein; equally unusual is the finding that 2-selenouridine is used in 
only three bases in the entire transcriptomes of bacteria possessing ybbB. 
A1 though several functions have been postulated for selenouridine, its 
function is not known. Based on the facts that 2-selenouridine is found 
exclusively at the wobble position of codons ending in a purine, and that 
these codons pose a problem for the translation machinery, it has been 
postulated that 2-selenouridine would have been an adjustment of the 
decoding apparatus to increase translational fidelity [7]. Whether this base 
modification occurs outside the bacterial domain is not known; a low 
identity homolog to bacterial ybbB is present in Methanococcus jannaschii 
and Methanopyrus kandleri [7,30]. 
Finally, the presence of a SPS homolog with high identity in Enterococcus 
faecalis, a species that neither decodes Sec nor possesses ybbB is interesting. 
Furthermore, a Sec lyase homolog and a protein involved in sulfur reduction 
flank this gene in the genome. This observation suggests that there may be 
an additional Se utilization trait that occurs in E. faecalis and perhaps other 
organisms (unpublished). 
Looking at the phenotype: evolution of selenoproteins is a highly 
dynamic process 
Evolution of selenoproteins is a highly dynamic process linked to the 
evolution of the Sec decoding trait itself. From the mechanistic point of 
view, this process involves: i) evolution of selenoproteins from Cys- 
containing homologs concomitant with the acquisition of SECIS elements 
[5], ii) evolution of Cys-containing proteins from selenoproteins (fossil 
SECIS elements have been well documented even in Sec decoding species) 
[4,31], iii) gene duplication [32,33], and iv) conceivably "invention" of 
entirely new selenoprotein families for which no Cys homologs have been 
detected (possibly the glycine reductase component, grdA, in bacteria [5,15], 
and SelJ in eukarya [5,34]). This highly dynamic process is at least in part 
due to the following processes: i) Sec and Cys can be replaced by each other 
concomitant with appropriate adjustments in the protein context [35] and/or 
protein concentration, and ii) the SECIS element appears to evolve easily, 
especially in archaea and eukarya, in which the 3'-UTR location of this 
structure is not constrained by the coding region. 
Yet, the evolutionary forces that shape Sec utilization, in particular the 
delicate balance between processes that maintain, acquire or lose this trait 
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are not clear. It has been previously postulated that the selective advantage 
provided by selenoenzymes over Cys-homologs (due to the better 
nucleophilicity and lower pKa of SeH in Sec over SH in Cys), might become 
a disadvantage if selenium supply becomes limiting [7,15,3 61. In these 
situations, enzymes containing Sec as catalytic residues could have evolved 
into Cys-containing proteins, or alternatively, both Sec-containing and Cys- 
containing forms could have been maintained allowing organisms to use Se 
in a facultative manner [36]. An illustrative example of a Se facultative 
organism is Methanococcus maripaludis, which represses the synthesis of 
the Cys homologs when grown in a medium that contains adequate amounts 
of Se, but this repression is not observed in a mutant with disrupted selB 
[36]. Nevertheless, the occurrence of organisms carrying only one of the 
selenium utilization traits indicates that Se availability might not be the sole 
factor involved in the loss of either trait. 
It is also of interest that selenoproteomes, while differing in size in 
composition between various organisms, always represent a very small 
subset of the total protein complement. One may consider Sec as a two- 
edged weapon - the advantage of having a highly reactive selenol group 
might become a disadvantage if used indiscriminately to replace Cys. This 
may restrict the pervasive use of Sec in the environments where Se supply 
may be adequate or excessive [7]. Another conspicuous feature of Sec 
utilization in nature is its idiosyncratic use by different taxa: different sets of 
selenoproteins have evolved in different lineages [6,34,3 71. This finding 
indicates adaptations in the use of Sec, presumably to fblfill particular needs. 
It has been suggested that both lineage-specific expansion (presumably of 
recent origin), and the presence of core selenoproteins (ancient origin) 
appear to contribute to extant selenoproteomes [S]. 
Analyses of prokaryotic selenoproteomes revealed that formate 
dehydrogenase is present in most Sec decoding organisms [$I, suggesting 
that under anaerobic respiration Sec-containing formate dehydrogenase 
confers a specific advantage [7]. Indeed, most of selenoprotein formate 
dehydrogenase-containing species are obligatory anaerobes or facultative 
aerobes; the sole exception appears to be S. melilloti, a symbiotic nitrogen- 
fixing obligatory aerobe that lives in the oxygen-limited environment of the 
nodule. On the other hand, glycine reductases, present in T. denticola, P. 
profundum, T. tengcongemis and several species of the genus Clostridium 
might have conferred a selective advantage allowing certain anaerobic 
bacteria to conserve energy via a soluble substrate level phosphorylation 
system [38]. 
Synthesis of S ~ C - ~ R N A ~ ~ :  a non-canonical mechanism 
A conspicuous feature of Sec synthesis is that it occurs on its tRNA, from 
s~~-~RNA&', which is then converted into S~C-~RNA*' using 
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monoselenophosphate as the selenium donor [39,40]. This latter reaction is 
catalyzed by Sec synthase (SelA) in the bacterial domain. The equivalent 
enzyme(s) in archaea and eukarya is (are) not known, although the 
mechanism is thought to involve a S ~ ~ - ~ R N A ' ~ '  intermediate 
(Sep=phosphoserine) w] . 
Table 1. Non-cognate charging of amino acids into tRNAs 
Nature has evolved two different mechanisms for synthesis of aminoacyl- 
tRNAs: i) the canonical one (i.e., a specific amino acyl tRNA synthetase 
recognizes an amino acid and its cognate tRNA), and ii) the non-canonical 
mechanism wherein the tRNA is loaded first with a "non-cognate" amino 
acid that is then modified to the amino acid to be incorporated into protein. 
Although the amino acid biosynthesis on a tRNA scaffold is not unique to 
Sec (Table 1, after [42] and [43]), it is interesting to point out that Sec is the 
sole example in which the second mechanism appears to occur in the three 
domains of life, and might be the predominant or even exclusive 
biosynthetic mechanism. It is also important to note that Sec synthesis 
appears to resemble Cys synthesis on tRNA in two aspects: i) in archaea and 
eukarya, s e r - t ~ ~ ~ ~ '  is first converted into S ~ ~ - ~ R N A ~ ~ ' ,  whereas Sep is the 
intermediate in Cys synthesis on tRNA in some archaea [44], and ii) 
synthesis of Cys on tRNA is the sole mechanism by which Cys is 
synthesized in a subset of archaea that use this strategy. It has been 
speculated that SepCysS (the enzyme that charges Sep directly to ~RNA'~)  
provided a means by which both Cys and Sec may have been originally 
added to the genetic code [MI. More generally, it could be speculated that in 
Asn 
CYS 
fMet 
Gln 
PY 1 
Sec 
Asp, Glu 
S ~ P  
Met 
Glu, Asp 
L YS 
Ser 
aspRS gluRS 
sepRS 
metRS 
gluRS aspRS 
IysRSl +lysRS2 
serRS 
archaea 
bacteria 
archaea 
bacteria, organelles 
archaea 
bacteria 
archaea 
archaea 
bacteria 
eu karya 
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situ synthesis of an amino acid provides a strategy by which the amino acid 
repertoire (and the genetic code) could have been, and conceivably can be 
expanded. 
Lessons from the genetic code 
Nearly four decades ago the genetic code was deciphered [45]. Yet, the 
signals involved in translation of information are neither universal nor 
completely known, and several mechanisms of reprogramming have been 
documented [46]. Sec decoding provides clues to how, with very few genes, 
a codon can be reprogrammed in specific messages, increasing the amino 
acid repertoire. In addition, it illustrates how flexible and dynamic is the 
evolution of the genetic code: the ability to decode Sec can be lost, but later 
reacquired by HGT of a handful of genes. The case of Sec is also interesting 
in that it is a "non-standard" amino acid that is co-translationally 
incorporated, but has not been fixed as the only (or major) function of UGA 
in the genetic code. In turn, this raises the question of why Sec has not been 
"hardwired" (i.e., reassigned a codon), and what are the differences between 
increasing the amino acid repertoire post-translationally or co- 
translationally. 
Stop codons have repeatedly evolved particular meanings (Trp, Cys, Sec, 
Pyl) either by codon reassignment or by reprogramming, suggesting that a 
change of meaning could be less deleterious for a nonsense codon. In 
particular, whether the UGA codon originally specified Sec or stop has been 
a matter of debate. It was speculated [16] that UGA evolved Erom sense to 
nonsense, and postulated a possible scenario where Sec was one of the 
earliest amino acids in evolutionary history. And once oxygen evolved in the 
atmosphere, the susceptibility to oxidation could have counterselected Sec 
resulting in the stop function of UGA and maintaining the Sec function by 
means of SECIS element and EF-sec. On the other hand, it was also 
proposed [47] that UGA evolved fiom nonsense to sense, and that Sec was 
added to the already fixed code. Although the question of the ancestral 
meaning of UGA is difficult to solve, the very need of reprogramming 
specific messages suggests that the Sec insertion has evolved on top of an 
existing translational machinery to acquire a new meaning for an already 
assigned codon. In other words, "loose" programming (for specific 
messages) must have been a novelty added to the "hardwired" code (i.e., 
universal, for all messages). 
Further clues to the idiosyncrasies of the genetic code and its dynamic 
evolution have arisen fiom pyrrolysine (Pyl), a recently discovered %on- 
standard" amino acid [48]. The mechanism of Pyl incorporation, in 
particular whether it requires recoding (and if it does, what are the signals) is 
not clear [49]. Although Sec and Pyl use dissimilar decoding strategies, there 
are clear parallels: Sec and Pyl are amino acids used in a small set of 
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proteins and both are expansions of the amino acid repertoire by redefining 
the meaning of stop codons. The diversity of mechanisms involved in 
translation, together with the simple machinery needed to expand the genetic 
code, opens the door to the possibility that 22 genetically encoded amino 
acids may not be the final number and that additional amino acids may exist 
in the genetic code. 
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